• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.一种用于计算回收率和结合率的质量平衡方法可使超滤成为一种快速测量方法,即使是对于高度脂溶性的化合物,也可用于测量其血浆蛋白结合率。
J Pharm Biomed Anal. 2013 Mar 5;75:112-7. doi: 10.1016/j.jpba.2012.11.018. Epub 2012 Nov 21.
2
Modulation of nonspecific binding in ultrafiltration protein binding studies.超滤蛋白结合研究中非特异性结合的调节
Pharm Res. 2003 Jul;20(7):1015-21. doi: 10.1023/a:1024406221962.
3
Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.快速平衡透析、超滤还是超速离心?评估定量血浆中物质未结合分数的方法。
Biochem Biophys Res Commun. 2023 Apr 9;651:114-120. doi: 10.1016/j.bbrc.2023.02.021. Epub 2023 Feb 10.
4
Pretreatment and non-specific binding in ultrafiltration device: Impact on protease inhibitor quantification.超滤装置预处理和非特异性结合:对蛋白酶抑制剂定量检测的影响。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jun 1;1146:122127. doi: 10.1016/j.jchromb.2020.122127. Epub 2020 Apr 24.
5
Plasma Protein Binding of Challenging Compounds.挑战性化合物的血浆蛋白结合
J Pharm Sci. 2015 Aug;104(8):2627-36. doi: 10.1002/jps.24506. Epub 2015 Jun 2.
6
Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.采用平衡透析变体对药物与血浆蛋白结合进行的研究。
J Pharm Biomed Anal. 2005 Jul 1;38(3):381-9. doi: 10.1016/j.jpba.2005.01.015. Epub 2005 Feb 24.
7
Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.用于血浆蛋白结合的高通量平衡透析测定法的开发与验证。
J Lab Autom. 2011 Feb;16(1):56-67. doi: 10.1016/j.jala.2010.06.002. Epub 2011 Jan 12.
8
Approaches to measure protein binding of enzymatically unstable compounds in plasma.测量血浆中酶不稳定化合物蛋白质结合的方法。
Bioanalysis. 2018 Apr 1;10(7):451-459. doi: 10.4155/bio-2017-0288. Epub 2018 Apr 10.
9
Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.血浆中丙吡胺游离分数的测定:平衡透析、通过透析膜超滤及使用抗惊厥药物超滤过滤器的比较
J Pharmacol Methods. 1982 Jan;7(1):7-14. doi: 10.1016/0160-5402(82)90053-5.
10
Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.通过平衡透析和超滤法测定丙吡胺的血浆蛋白结合率。
Ther Drug Monit. 1983;5(1):81-6. doi: 10.1097/00007691-198303000-00007.

引用本文的文献

1
A Sequential Ultrafiltration Method to Enhance the Accuracy and Throughput in Plasma Protein Binding Tests.一种提高血浆蛋白结合试验准确性和通量的序贯超滤方法。
Pharmaceutics. 2025 Feb 18;17(2):273. doi: 10.3390/pharmaceutics17020273.
2
Determination of unbound platinum concentrations in human plasma using ultrafiltration and precipitation methods.采用超滤和沉淀法测定人血浆中游离铂浓度。
J Pharmacol Toxicol Methods. 2024 Jul-Aug;128:107535. doi: 10.1016/j.vascn.2024.107535. Epub 2024 Jun 30.
3
A Sensitive Assay for Unbound Docetaxel Using Ultrafiltration plus HPLC-MS and Its Application to a Clinical Study.一种使用超滤结合高效液相色谱-质谱联用技术测定游离多西他赛的灵敏方法及其在一项临床研究中的应用。
Pharmaceutics. 2024 Apr 29;16(5):602. doi: 10.3390/pharmaceutics16050602.
4
Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.全氟及多氟烷基物质基于类别毒代动力学评估的血浆蛋白结合评估。
Chem Res Toxicol. 2023 Jun 19;36(6):870-881. doi: 10.1021/acs.chemrestox.3c00003. Epub 2023 May 15.
5
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models.多黏菌素 B 在大肠埃希菌和肺炎克雷伯菌小鼠感染模型中的药代动力学和药效学特性。
J Antimicrob Chemother. 2023 Mar 2;78(3):832-839. doi: 10.1093/jac/dkad022.
6
Plasma Protein Binding Rate and Pharmacokinetics of Lekethromycin in Rats.来克红霉素在大鼠体内的血浆蛋白结合率及药代动力学
Antibiotics (Basel). 2022 Sep 13;11(9):1241. doi: 10.3390/antibiotics11091241.
7
Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor.新型口服蛋白酶体抑制剂 FHND6091 的临床前药代动力学、组织分布和体外代谢研究。
Drug Des Devel Ther. 2022 Sep 13;16:3087-3107. doi: 10.2147/DDDT.S371020. eCollection 2022.
8
Discovery of Orally Bioavailable and Brain-Penetrable Prodrugs of the Potent nSMase2 Inhibitor DPTIP.发现强效 nSMase2 抑制剂 DPTIP 的可口服生物利用度和可穿透血脑屏障的前药。
J Med Chem. 2022 Aug 25;65(16):11111-11125. doi: 10.1021/acs.jmedchem.2c00562. Epub 2022 Aug 5.
9
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity.强力霉素抑制假型病毒转导并不意味着能抑制 SARS-CoV-2 感染性。
Viruses. 2021 Sep 1;13(9):1745. doi: 10.3390/v13091745.
10
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications.血浆蛋白结合对抗癫痫药物治疗监测的影响。
Pharmaceutics. 2021 Aug 5;13(8):1208. doi: 10.3390/pharmaceutics13081208.

本文引用的文献

1
Determination of compound binding to plasma proteins.化合物与血浆蛋白结合的测定。
Curr Protoc Pharmacol. 2006 Oct;Chapter 7:Unit7.5. doi: 10.1002/0471141755.ph0705s34.
2
Compilation of 222 drugs' plasma protein binding data and guidance for study designs.222 种药物的血浆蛋白结合数据汇编及研究设计指南。
Drug Discov Today. 2012 May;17(9-10):475-85. doi: 10.1016/j.drudis.2011.12.018. Epub 2011 Dec 23.
3
Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor.化学抑制 RNA 病毒揭示 REDD1 是一种宿主防御因子。
Nat Chem Biol. 2011 Sep 11;7(10):712-9. doi: 10.1038/nchembio.645.
4
Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry.采用快速平衡透析结合固相萃取和高效液相色谱-质谱联用技术测定人血浆中非结合型维莫德吉(GDC-0449)浓度。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 15;879(22):2119-26. doi: 10.1016/j.jchromb.2011.05.048. Epub 2011 Jun 12.
5
Development of proneurogenic, neuroprotective small molecules.促神经生成、神经保护的小分子的研发。
J Am Chem Soc. 2011 Feb 9;133(5):1428-37. doi: 10.1021/ja108211m. Epub 2011 Jan 6.
6
Evaluation of in situ albumin binding surfaces: a study of protein adsorption and platelet adhesion.原位白蛋白结合表面的评估:蛋白质吸附和血小板黏附的研究。
J Mater Sci Mater Med. 2011 Jan;22(1):137-49. doi: 10.1007/s10856-010-4169-3. Epub 2010 Dec 1.
7
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.Wnt反应小分子抑制剂的构效关系研究
Bioorg Med Chem Lett. 2009 Jul 15;19(14):3825-7. doi: 10.1016/j.bmcl.2009.04.040. Epub 2009 Apr 18.
8
Targeting QseC signaling and virulence for antibiotic development.靶向QseC信号传导和毒力用于抗生素研发。
Science. 2008 Aug 22;321(5892):1078-80. doi: 10.1126/science.1160354.
9
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.对670种药物化合物的人体静脉药代动力学参数数据库进行趋势分析。
Drug Metab Dispos. 2008 Jul;36(7):1385-405. doi: 10.1124/dmd.108.020479. Epub 2008 Apr 21.
10
Impact of pH on plasma protein binding in equilibrium dialysis.pH对平衡透析中血浆蛋白结合的影响。
Mol Pharm. 2008 May-Jun;5(3):438-48. doi: 10.1021/mp800004s. Epub 2008 Mar 18.

一种用于计算回收率和结合率的质量平衡方法可使超滤成为一种快速测量方法,即使是对于高度脂溶性的化合物,也可用于测量其血浆蛋白结合率。

A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.

机构信息

Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

出版信息

J Pharm Biomed Anal. 2013 Mar 5;75:112-7. doi: 10.1016/j.jpba.2012.11.018. Epub 2012 Nov 21.

DOI:10.1016/j.jpba.2012.11.018
PMID:23312388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3545278/
Abstract

The aim of this study is to further validate the use of ultrafiltration (UF) as a method for determining plasma protein binding (PPB) by demonstrating that non-specific binding (NSB) is not a limitation, even for highly lipophilic compounds, because NSB sites on the apparatus are passivated in the presence of plasma. Mass balance theory was used to calculate recovery of 20 commercial and seven investigational compounds during ultrafiltration in the presence and absence of plasma. PPB was also measured using this mass balance approach for comparison to PPB determined by rapid equilibrium dialysis (RED) and as found in the literature. Compound recovery during UF was dramatically different in the presence and absence of plasma for compounds with high NSB in PBS only. A comparison of PPB calculated by ultrafiltration with literature values or calculated by RED gave concordant results. Discrepancies could be explained by changes in pH, insufficient time to equilibrium, or compound instability during RED, problems which were circumvented by ultrafiltration. Therefore, NSB, as measured by the traditional incubation of compound in PBS, need not be an issue when choosing UF as a PPB assay method. It is more appropriate to calculate compound recovery from the device in plasma as measured by mass balance to determine the suitability of the method for an individual compound. The speed with which UF can be conducted additionally avoids changes in pH or compound loss that can occur with other methods. The mass balance approach to UF is thus a preferred method for rapid determination of PPB.

摘要

本研究旨在进一步验证超滤(UF)作为一种测定血浆蛋白结合率(PPB)的方法,方法是证明非特异性结合(NSB)不是限制因素,即使是对高度亲脂性化合物也是如此,因为在存在血浆的情况下,仪器上的 NSB 位点被钝化。使用质量平衡理论计算了 20 种商业化合物和 7 种研究化合物在存在和不存在血浆的情况下超滤过程中的回收率。还使用这种质量平衡方法测定了 PPB,并与通过快速平衡透析(RED)测定的 PPB 进行了比较,以及与文献中的值进行了比较。对于仅在 PBS 中具有高 NSB 的化合物,在存在和不存在血浆的情况下,UF 过程中的化合物回收率差异很大。超滤法计算的 PPB 与文献值或 RED 计算的 PPB 进行比较,结果一致。差异可以用 pH 值的变化、平衡时间不足或 RED 过程中化合物的不稳定性来解释,这些问题通过超滤得到了避免。因此,当选择 UF 作为 PPB 测定方法时,通过传统的在 PBS 中孵育化合物来测量的 NSB 不必成为问题。更适合的方法是根据质量平衡从血浆中测定设备中的化合物回收率,以确定该方法对单个化合物的适用性。UF 进行的速度还可以避免其他方法中可能发生的 pH 值变化或化合物损失。因此,质量平衡法 UF 是快速测定 PPB 的首选方法。